Despite the mechanism by which WT1 silencing or mutations lead to decreased 5-hmC is not completely clarified, the TET2, IDH1/2, and WT1 mutations lead to dysregulated DNA hydroxymethylation, which could be classified as a new subtype of AML. This evidence concerns the gene TET2 and acute myeloid leukemia.